期刊
FRONTIERS IN IMMUNOLOGY
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.03070
关键词
pancreatic cancer; immunosuppression; MDSC; Tregs; immune cell interactions
类别
资金
- INSERM (Paris, France)
- Aix-Marseille Universite (Marseille, France)
- grant INCa-DGSO-INSERM from Sites de Recherche Integree sur le Cancer (SIRIC)
- Canceropole Provence-Alpes-Cote d'Azur (Marseille, France)
- French National Research Agency through the Investissements d'Avenir program (FranceBioImaging) [ANR-10-INBS-04]
- FRM Amorcage jeunes equipes [AJE20150633331]
- ANR ACHN [ANR-16-ACHN-0011]
- A* midex Chaire d'excellence
- Agence Nationale de la Recherche (ANR) [ANR-16-ACHN-0011] Funding Source: Agence Nationale de la Recherche (ANR)
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising incidence and a remarkable resistance to current therapies. The reasons for this therapeutic failure include the tumor's extensive infiltration by immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs). By using light sheet fluorescent microscopy, we identified here direct interactions between these major immunoregulatory cells in PDAC. The in vivo depletion of MDSCs led to a significant reduction in Tregs in the pancreatic tumors. Through videomicroscopy and ex vivo functional assays we have shown that (i) MDSCs are able to induce Treg cells in a cell-cell dependent manner; (ii) Treg cells affect the survival and/or the proliferation of MDSCs. Furthermore, we have observed contacts between MDSCs and Treg cells at different stages of human cancer. Overall our findings suggest that interactions between MDSCs and Treg cells contribute to PDAC immunosuppressive environment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据